A phase II study of osimertinib in patients with NSCLC harboring EGFR exon 20 insertion: A multicenter trial of the Korean Cancer Study Group (LU17-19).
Yu Jung KimSoyeon KimTae Min KimKoung Jin SuhMiso KimSe Hyun KimBhumsuk KeamDong-Wan KimJong Seok LeeDae Seog HeoPublished in: Lung cancer (Amsterdam, Netherlands) (2024)
govIdentifier: NCT03414814.
Keyphrases
- small cell lung cancer
- phase ii study
- epidermal growth factor receptor
- advanced non small cell lung cancer
- open label
- papillary thyroid
- locally advanced
- phase iii
- study protocol
- clinical trial
- squamous cell
- phase ii
- cross sectional
- radiation therapy
- double blind
- young adults
- childhood cancer
- rectal cancer
- lymph node metastasis